Hôpital de la Cité-de-la-Santé

Laval, Quebec H7M 3L9

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Relapsed Small Cell Lung Cancer

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) — Stopped early